Analyze Diet
Cell communication and signaling : CCS2022; 20(1); 137; doi: 10.1186/s12964-022-00923-2

Mitochondria transfer restores fibroblasts-like synoviocytes (FLS) plasticity in LPS-induced, in vitro synovitis model.

Abstract: Synovitis (SI) is one of the most common and serious orthopedic diseases in horses of different age, breed and sex, which contributes to the development of osteoarthritis. The burden of SI includes economic loss and represents a real challenge for current veterinary health care. At the molecular level, fibroblasts-like synoviocytes (FLS) are recognized as major cell populations involved in SI pathogenesis. In the course of SI, FLSs are losing their protective and pro-regenerative cytological features, become highly proliferative and initiate various stress signaling pathways. Fibroblast-like synoviocytes were treated with LPS in order to generate SI in vitro model. Mitochondria were isolated from peripheral blood derived mononuclear cells and co-cultured with FLS. After 24 h of culture, cells were subjected to RT-qPCR, western blot, cytometric and confocal microscopy analysis. Mitochondrial transfer (MT) was observed in vitro studies using confocal microscopy. Further studies revealed, that MT to LPS-treated FLS reduced cell proliferation, modulated apoptosis and decreased inflammatory response. Overall, MT Resulted in the considerable recovery of recipient cells cytophysiological properties. Presented data provides evidence that mitochondria transfersignificantly modulate FLS proliferative and metabolic activity through improved mitochondrial biogenesis and dynamics in activated FLS. Obtained results for the first time demonstrate that horizontal MT might be considered as a therapeutic tool for synovitis treatment; however, further clinical studies are strongly required. Video abstract.
Publication Date: 2022-09-07 PubMed ID: 36071528PubMed Central: PMC9450291DOI: 10.1186/s12964-022-00923-2Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Video-Audio Media
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study explores the potential therapeutic impact of transferring mitochondria to fibroblasts-like synoviocytes (FLS) to restore their functionality in the case of synovitis (a common orthopedic disease in horses) induced in-vitro (lab conditions), demonstrating positive effects on cellular health and a reduction in inflammation.

Overview of the Problem

  • Synovitis (SI) is a severe orthopedic issue commonly affecting horses. SI leads to significant economic losses and challenges for veterinary healthcare professional.
  • Fibroblasts-like synoviocytes (FLS) are crucial cell groups linked to the SI’s pathology. When SI develops, these cells lose their cell-protective and pro-regenerative characteristics, become hyper-proliferative, and initiate stress signaling pathways.

Research Methodology

  • To create a model of SI under lab conditions, FLS were exposed to Lipopolysaccharides (LPS).
  • Mitochondria were derived from peripheral blood mononuclear cells and co-cultivated with FLS.
  • Post a 24-hour culture period, the cells were analyzed using RT-qPCR, western blot, cytometry, and confocal microscopy. The transfer of mitochondria was visualized via confocal microscopy.

Key Findings

  • The transfer of mitochondria to LPS-treated FLS was observed to reduce cell proliferation, modulate apoptosis (cell death), and diminish the inflammatory response.
  • Overall, the transfer of mitochondria led to a significant recovery in the cytophysiological properties of the recipient cells.
  • It was seen that the mitochodrial transfer greatly adjusted FLS’s proliferative and metabolic activity via improved mitochondrial biogenesis (growth and division of pre-existing mitochondria) and dynamics among activated FLS.

Conclusions and Future Directions

  • The data serves as the first evidence demonstrating that horizontal mitochondrial transfer might be a potential treatment method for SI.
  • However, the study suggests a necessity for more clinical trials to further validate the therapy.

Cite This Article

APA
Kornicka-Garbowska K, Groborz S, Lynda B, Galuppo L, Marycz K. (2022). Mitochondria transfer restores fibroblasts-like synoviocytes (FLS) plasticity in LPS-induced, in vitro synovitis model. Cell Commun Signal, 20(1), 137. https://doi.org/10.1186/s12964-022-00923-2

Publication

ISSN: 1478-811X
NlmUniqueID: 101170464
Country: England
Language: English
Volume: 20
Issue: 1
Pages: 137
PII: 137

Researcher Affiliations

Kornicka-Garbowska, K
  • Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Norwida 27B Street, A7 Building, 50-375, Wroclaw, Poland.
  • International Institute of Translational Medicine, Malin, Jesionowa 11, 55-114, Wisznia Mała, Poland.
Groborz, S
  • International Institute of Translational Medicine, Malin, Jesionowa 11, 55-114, Wisznia Mała, Poland.
Lynda, B
  • Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Norwida 27B Street, A7 Building, 50-375, Wroclaw, Poland.
Galuppo, L
  • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Marycz, K
  • Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Norwida 27B Street, A7 Building, 50-375, Wroclaw, Poland. kmmarycz@ucdavis.edu.
  • International Institute of Translational Medicine, Malin, Jesionowa 11, 55-114, Wisznia Mała, Poland. kmmarycz@ucdavis.edu.
  • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA. kmmarycz@ucdavis.edu.

MeSH Terms

  • Animals
  • Cells, Cultured
  • Fibroblasts / metabolism
  • Horses
  • Lipopolysaccharides / pharmacology
  • Mitochondria
  • Synoviocytes / metabolism
  • Synovitis / metabolism

Conflict of Interest Statement

The authors declare no competing interests.

References

This article includes 29 references
  1. Kannegieter NJ. Chronic proliferative synovitis of the equine metacarpophalangeal joint.. Vet Rec 1990 Jul 7;127(1):8-10.
    pubmed: 2385919
  2. Ross TN, Kisiday JD, Hess T, McIlwraith CW. Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide.. Osteoarthritis Cartilage 2012 Dec;20(12):1583-90.
    doi: 10.1016/j.joca.2012.08.008pubmed: 22917743google scholar: lookup
  3. Bustamante MF, Garcia-Carbonell R, Whisenant KD, Guma M. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis.. Arthritis Res Ther 2017 May 31;19(1):110.
    doi: 10.1186/s13075-017-1303-3pmc: PMC5452638pubmed: 28569176google scholar: lookup
  4. Yang J, Wang J, Liang X, Zhao H, Lu J, Ma Q, Jing B, Tian F. IL‑1β increases the expression of inflammatory factors in synovial fluid‑derived fibroblast‑like synoviocytes via activation of the NF‑κB‑mediated ERK‑STAT1 signaling pathway.. Mol Med Rep 2019 Dec;20(6):4993-5001.
    pmc: PMC6854543pubmed: 31638264doi: 10.3892/mmr.2019.10759google scholar: lookup
  5. Ahn JK, Kim S, Hwang J, Kim J, Kim KH, Cha HS. GC/TOF-MS-based metabolomic profiling in cultured fibroblast-like synoviocytes from rheumatoid arthritis.. Joint Bone Spine 2016 Dec;83(6):707-713.
    doi: 10.1016/j.jbspin.2015.11.009pubmed: 27133762google scholar: lookup
  6. Bauer S, Jendro MC, Wadle A, Kleber S, Stenner F, Dinser R, Reich A, Faccin E, Gödde S, Dinges H, Müller-Ladner U, Renner C. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes.. Arthritis Res Ther 2006;8(6):R171.
    doi: 10.1186/ar2080pmc: PMC1794515pubmed: 17105646google scholar: lookup
  7. Tu J, Hong W, Zhang P, Wang X, Körner H, Wei W. Ontology and Function of Fibroblast-Like and Macrophage-Like Synoviocytes: How Do They Talk to Each Other and Can They Be Targeted for Rheumatoid Arthritis Therapy?. Front Immunol 2018;9:1467.
    doi: 10.3389/fimmu.2018.01467pmc: PMC6028561pubmed: 29997624google scholar: lookup
  8. Tu J, Wang X, Gong X, Hong W, Han D, Fang Y, Guo Y, Wei W. Synovial Macrophages in Rheumatoid Arthritis: The Past, Present, and Future.. Mediators Inflamm 2020;2020:1583647.
    doi: 10.1155/2020/1583647pmc: PMC7174945pubmed: 32351318google scholar: lookup
  9. Wang X, Chen Z, Fan X, Li W, Qu J, Dong C, Wang Z, Ji Z, Li Y. Inhibition of DNM1L and mitochondrial fission attenuates inflammatory response in fibroblast-like synoviocytes of rheumatoid arthritis.. J Cell Mol Med 2020 Jan;24(2):1516-1528.
    doi: 10.1111/jcmm.14837pmc: PMC6991664pubmed: 31755231google scholar: lookup
  10. Al-Azab M, Qaed E, Ouyang X, Elkhider A, Walana W, Li H, Li W, Tang Y, Adlat S, Wei J, Wang B, Li X. TL1A/TNFR2-mediated mitochondrial dysfunction of fibroblast-like synoviocytes increases inflammatory response in patients with rheumatoid arthritis via reactive oxygen species generation.. FEBS J 2020 Jul;287(14):3088-3104.
    doi: 10.1111/febs.15181pubmed: 31953914google scholar: lookup
  11. Jackson MV, Morrison TJ, Doherty DF, McAuley DF, Matthay MA, Kissenpfennig A, O'Kane CM, Krasnodembskaya AD. Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS.. Stem Cells 2016 Aug;34(8):2210-23.
    doi: 10.1002/stem.2372pmc: PMC4982045pubmed: 27059413google scholar: lookup
  12. Pang Y, Zhang C, Gao J. Macrophages as Emerging Key Players in Mitochondrial Transfers.. Front Cell Dev Biol 2021;9:747377.
    doi: 10.3389/fcell.2021.747377pmc: PMC8548694pubmed: 34722528google scholar: lookup
  13. Yuan Y, Yuan L, Li L, Liu F, Liu J, Chen Y, Cheng J, Lu Y. Mitochondrial transfer from mesenchymal stem cells to macrophages restricts inflammation and alleviates kidney injury in diabetic nephropathy mice via PGC-1α activation.. Stem Cells 2021 Jul;39(7):913-928.
    doi: 10.1002/stem.3375pubmed: 33739541google scholar: lookup
  14. Jiang D, Gao F, Zhang Y, Wong DS, Li Q, Tse HF, Xu G, Yu Z, Lian Q. Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage.. Cell Death Dis 2016 Nov 10;7(11):e2467.
    doi: 10.1038/cddis.2016.358pmc: PMC5260876pubmed: 27831562google scholar: lookup
  15. Kornicka K, Szłapka-Kosarzewska J, Śmieszek A, Marycz K. 5-Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy.. J Cell Mol Med 2019 Jan;23(1):237-259.
    doi: 10.1111/jcmm.13914pmc: PMC6307768pubmed: 30370650google scholar: lookup
  16. Fu A, Shi X, Zhang H, Fu B. Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice.. Front Pharmacol 2017;8:241.
    doi: 10.3389/fphar.2017.00241pmc: PMC5422541pubmed: 28536524google scholar: lookup
  17. Marycz K, Kornicka K, Basinska K, Czyrek A. Equine Metabolic Syndrome Affects Viability, Senescence, and Stress Factors of Equine Adipose-Derived Mesenchymal Stromal Stem Cells: New Insight into EqASCs Isolated from EMS Horses in the Context of Their Aging.. Oxid Med Cell Longev 2016;2016:4710326.
    pmc: PMC4670679pubmed: 26682006doi: 10.1155/2016/4710326google scholar: lookup
  18. Alicka M, Major P, Wysocki M, Marycz K. Adipose-Derived Mesenchymal Stem Cells Isolated from Patients with Type 2 Diabetes Show Reduced "Stemness" through an Altered Secretome Profile, Impaired Anti-Oxidative Protection, and Mitochondrial Dynamics Deterioration.. J Clin Med 2019 May 30;8(6).
    doi: 10.3390/jcm8060765pmc: PMC6617220pubmed: 31151180google scholar: lookup
  19. Macheiner T, Fengler VH, Agreiter M, Eisenberg T, Madeo F, Kolb D, Huppertz B, Ackbar R, Sargsyan K. Magnetomitotransfer: An efficient way for direct mitochondria transfer into cultured human cells.. Sci Rep 2016 Oct 21;6:35571.
    doi: 10.1038/srep35571pmc: PMC5073296pubmed: 27767193google scholar: lookup
  20. Chang JC, Liu KH, Li YC, Kou SJ, Wei YH, Chuang CS, Hsieh M, Liu CS. Functional recovery of human cells harbouring the mitochondrial DNA mutation MERRF A8344G via peptide-mediated mitochondrial delivery.. Neurosignals 2013;21(3-4):160-73.
    doi: 10.1159/000341981pubmed: 23006856google scholar: lookup
  21. Caicedo A, Fritz V, Brondello JM, Ayala M, Dennemont I, Abdellaoui N, de Fraipont F, Moisan A, Prouteau CA, Boukhaddaoui H, Jorgensen C, Vignais ML. MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function.. Sci Rep 2015 Mar 13;5:9073.
    doi: 10.1038/srep09073pmc: PMC4358056pubmed: 25766410google scholar: lookup
  22. Palmer JL, Bertone AL. Experimentally-induced synovitis as a model for acute synovitis in the horse.. Equine Vet J 1994 Nov;26(6):492-5.
  23. Cabrera F, Ortega M, Velarde F, Parra E, Gallardo S, Barba D, Soto L, Peña G, Pedroza LA, Jorgensen C, Khoury M, Caicedo A. Primary allogeneic mitochondrial mix (PAMM) transfer/transplant by MitoCeption to address damage in PBMCs caused by ultraviolet radiation.. BMC Biotechnol 2019 Jun 28;19(1):42.
    doi: 10.1186/s12896-019-0534-6pmc: PMC6599354pubmed: 31253149google scholar: lookup
  24. Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53.. Oncogene 2013 Oct 24;32(43):5129-43.
    doi: 10.1038/onc.2012.640pubmed: 23416979google scholar: lookup
  25. Takasugi K, Nishida K, Natsumeda M, Yamashita M, Yamamoto W, Ezawa K. IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis.. Mod Rheumatol 2018 May;28(3):452-460.
    doi: 10.1080/14397595.2017.1361802pubmed: 28828944google scholar: lookup
  26. Sweeney SE, Firestein GS. Mitogen activated protein kinase inhibitors: where are we now and where are we going?. Ann Rheum Dis 2006 Nov;65 Suppl 3(Suppl 3):iii83-8.
    pmc: PMC1798373pubmed: 17038480doi: 10.1136/ard.2006.058388google scholar: lookup
  27. Sweeney SE, Firestein GS. Primer: signal transduction in rheumatic disease--a clinician's guide.. Nat Clin Pract Rheumatol 2007 Nov;3(11):651-60.
    doi: 10.1038/ncprheum0631pubmed: 17968336google scholar: lookup
  28. Emani SM, Piekarski BL, Harrild D, Del Nido PJ, McCully JD. Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury.. J Thorac Cardiovasc Surg 2017 Jul;154(1):286-289.
    doi: 10.1016/j.jtcvs.2017.02.018pubmed: 28283239google scholar: lookup
  29. Lightowlers RN, Chrzanowska-Lightowlers ZM, Russell OM. Mitochondrial transplantation-a possible therapeutic for mitochondrial dysfunction?: Mitochondrial transfer is a potential cure for many diseases but proof of efficacy and safety is still lacking.. EMBO Rep 2020 Sep 3;21(9):e50964.
    doi: 10.15252/embr.202050964pmc: PMC7507022pubmed: 32852136google scholar: lookup

Citations

This article has been cited 2 times.
  1. Kornicka-Garbowska K, Groborz S, Lynda B, Galuppo L, Marycz K. Correction: Mitochondria transfer restores fibroblasts-like synoviocytes (FLS) plasticity in LPS-induced, in vitro synovitis model.. Cell Commun Signal 2023 Jun 12;21(1):128.
    doi: 10.1186/s12964-023-01187-0pubmed: 37308862google scholar: lookup
  2. Jing W, Liu C, Su C, Liu L, Chen P, Li X, Zhang X, Yuan B, Wang H, Du X. Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs.. Front Immunol 2023;14:1107670.
    doi: 10.3389/fimmu.2023.1107670pubmed: 36845127google scholar: lookup